LiGHT 2026

Rapid Medical Receives Approval for World’s Only Adjustable Thrombectomy Device in China

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Related stories

WebMD Ignite Ruby Transforms Healthcare Marketing...

WebMD Ignite has announced the launch of WebMD Ignite...

Mayo Clinic Study Validates AI Tool...

Researchers at Mayo Clinic have found that an artificial...

MHRA Outlines New Agenda for AI...

The United Kingdom’s Medicines and Healthcare products Regulatory Agency...

Rapid Medical has received approval from the National Medical Products Administration (NMPA) in China for its TIGERTRIEVER revascularization device.

TIGERTRIEVER becomes the first device capable of providing personalised solutions for removing blood clots from the brain, marking a significant advancement in the treatment of ischaemic stroke

This new approval of TIGERTRIEVER advances the treatment of ischaemic stroke patients in China. TIGERTRIEVER offers doctors a new range of neurological treatment devices to benefit more patients.

TIGERTRIEVER, with aerospace-inspired technology, offers precise control in mechanical thrombectomy. This unique technology shifts the procedure from a passive to an active approach, improving clot capture speed and potentially lowering the risk of vascular injury during removal. In contrast, leading stent retrievers are self-expanding and static, which can result in suboptimal clot removal and minimal vessel protection.

The successful introduction of the TIGERTRIEVER in China signifies a remarkable breakthrough in stroke intervention. This innovative device introduces the concept of customised thrombectomy through the use of an adjustable stent retriever, providing physicians with enhanced control to navigate procedures and effectively address unexpected challenges in real-world clinical settings.

Never miss a healthcare headline

Healthcare moves fast – stay on top of it with our must - read briefings.

  • The top hospital and healthcare stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments transforming global healthcare management

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

– Leave Message for Us to Get Back

Latest stories

Related stories

Mayo Clinic Study Validates AI Tool DEXI for Skin Lesion Assessment

Researchers at Mayo Clinic have found that an artificial...

MHRA Outlines New Agenda for AI Medical Devices at AdvaMed

The United Kingdom’s Medicines and Healthcare products Regulatory Agency...

UK Confirms Indefinite Use of CE Marked Medical Devices

The United Kingdom government has officially confirmed the indefinite...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »